Navigation Links
Annual Economic Impact of Chronic Disease on Ohio Economy is $56.8 Billion
Date:3/20/2008

Impact not inevitable with improved treatment and prevention of chronic

disease

CLEVELAND, March 20 /PRNewswire-USNewswire/ -- In a groundbreaking study released by the Milken Institute, the annual economic impact on Ohio's economy of the most common chronic diseases is calculated to be $56.8 billion. In the U.S. as a whole, the cost is a staggering $1 trillion, which could balloon to nearly $6 trillion by the middle of the century. Yet the news is not entirely grim because much of this cost is avoidable.

"An Unhealthy America: The Economic Burden of Chronic Disease" brings to light for the first time what is often overlooked in the discussion of the impact of chronic disease -- the economic loss associated with preventable illness and the cost to the nation's Gross Domestic Product (GDP) and American businesses in lost growth.

The results of the study were released at a joint forum hosted today by the Cleveland Clinic, University Hospitals, Rainbow Babies & Children's Hospital, the City of Cleveland Health Department and Cuyahoga County Board of Health, and the Ohio chapter of the Partnership to Fight Chronic Disease.

"The human toll of chronic disease in Ohio and the United States as a whole is obvious," said Matt Carroll, Health Director for the City of Cleveland. "The data presented by the Milken Institute today highlights the true cost burden of our failure to address chronic disease. We must reduce the rate of chronic disease to avoid potentially devastating economic damage to our state and nation."

According to the study, seven chronic diseases -- cancer, diabetes, hypertension, stroke, heart disease, pulmonary conditions and mental illness -- have a total impact on Ohio's economy of nearly $56.8 billion annually. Of this amount, $43.4 billion represents the cost of lost productivity. The national numbers are $1.3 trillion and $1.1 trillion, respectively.

"By investing in good
'/>"/>

SOURCE The Partnership to Fight Chronic Disease; The MilkenInstitute
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. NARSADs 5th Annual Mission Possible Symposium Offers Insight to PTSD and Other Mental Illnesses
2. Mirion Technologies to Showcase New Product Offerings for the Nuclear Industry During 10th Annual China International Nuclear Industry Exhibition
3. Abaxis, Inc. to Present at the Sidoti & Company Twelfth Annual New York Emerging Growth Institutional Investor Forum
4. ULURU Inc. to Present at Cowen and Company 28th Annual Health Care Conference 2008
5. Transdel Pharmaceuticals to Present at Cowen and Companys 28th Annual Health Care Conference
6. Flagship Global Health Announces Annual Meeting
7. Transition Therapeutics to Present at Cowen & Company 28th Annual Healthcare Conference
8. Covance to Present at Lehman Brothers 11th Annual Global Healthcare Conference
9. West Pharmaceutical Services to Present at the Lehman Brothers Eleventh Annual Global Healthcare Conference
10. Exelixis Announces March 19 Webcast of Presentation at the Lehman Brothers Annual Global Healthcare Conference
11. Edwards Lifesciences to Present at the Citi 5th Annual Small and Mid-Cap Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... As a result of C3: Colorectal Cancer Coalition,s advocacy ... research program is included in the final Fiscal Year ... research program will research cancers, like colorectal cancer, that ... ovarian cancer research programs run by the U.S. Army ... $15 million in funding for this new cancer research ...
(Date:12/16/2009)... Institute announce the first comprehensive analyses of cancer genomes. ... the DNA of cancer cells which are acquired during ... and a lung cancer, reveal for the first time ... cancers. , Lung cancer causes around one million deaths ... The number of mutations found suggest that a typical ...
(Date:12/16/2009)... Cost-Effective Care , ... Washington, D.C. (Vocus) December 16, ... ways to rein in runaway costs while providing care to all ... the ongoing discussion includes how to ensure patients equal access to ... (MDs) or osteopathy (DOs). In both the House and Senate ...
(Date:12/16/2009)... through annual marketing campaign , ... ... 2010 Genetown™ Hotbed Campaign as its largest yearly ... sponsored by MassBio and showcases 37 Massachusetts companies ... each entity’s brand on an electronic and printed map ...
(Date:12/16/2009)... Inc., developers of the AcceleDent System , ... announced Alison Davies as its new Director of ... spent the last fourteen years of her professional ... nine years as a senior manager with ... ,, (Logo: http://www.newscom.com/cgi-bin/prnh/20091029/DA01250LOGO ) ,, ...
Breaking Medicine News(10 mins):Health News:House Creates New Cancer Research Program 2Health News:House Creates New Cancer Research Program 3Health News:Lung cancer and melanoma laid bare 2Health News:Lung cancer and melanoma laid bare 3Health News:Lung cancer and melanoma laid bare 4Health News:Lung cancer and melanoma laid bare 5Health News:Lung cancer and melanoma laid bare 6Health News:Coalition for Patients' Rights: Access to Broad Range of Health Care Providers Critical to Lowering Costs 2Health News:Coalition for Patients' Rights: Access to Broad Range of Health Care Providers Critical to Lowering Costs 3Health News:Coalition for Patients' Rights: Access to Broad Range of Health Care Providers Critical to Lowering Costs 4Health News:Coalition for Patients' Rights: Access to Broad Range of Health Care Providers Critical to Lowering Costs 5Health News:Thriving Bioscience Region Leaves Its Mark 2Health News:Top-performing Sales Manager Joins OrthoAccel Technologies, Inc. in the United Kingdom 2Health News:Top-performing Sales Manager Joins OrthoAccel Technologies, Inc. in the United Kingdom 3Health News:Top-performing Sales Manager Joins OrthoAccel Technologies, Inc. in the United Kingdom 4
... room, The Flag Company, Inc.,s new ,Feel Good, Light Lenses are ... during this trying economical time. , ... (PRWEB) March ... has gripped the nation, the Flag Company, Inc. recently launched ,Feel ...
... at the KK Women,s and Children,s Hospital (KKH) can now opt ... an anesthetic-free yet almost painless operation to treat uterine fibroids. ... ... at the KK Women,s and Children,s Hospital (KKH) can ...
... the first in a series of residential vacuum cleaner reviews conducted in ... ... Idaho (Vocus) March 3, 2009 -- Before spending hundreds of dollars on ... savvy shoppers turn to the Internet to research their choices. , , ...
... March 3 Based on its recent analysis ... Sullivan recognizes Aesku.Diagnostics with the 2008 European Frost ... consistent approach towards product development. It has anticipated ... offered versatile immunoassay systems, extended research capabilities as ...
... /PRNewswire/ -- ... a division of United Business Media Limited, has signed ... to provide an integrated medicine management system for two ... Data Solutions are already used in approximately 700 hospitals ...
... The southeast Pacific nation of Papua New Guinea, home ... Earth, has created its first national conservation area to ... than Singapore. , The decision by the Papua New ... the newly established YUS Conservation Area, results from more ...
Other Medicine News:Health News:The Flag Company, Inc. Releases 'Feel Good' Light Lenses to Help Counter Gloomy Economic Outlook 2Health News:The Flag Company, Inc. Releases 'Feel Good' Light Lenses to Help Counter Gloomy Economic Outlook 3Health News:Singapore Premier Women's Hospital Offers Contactless Surgery for Uterine Fibroids 2Health News:Singapore Premier Women's Hospital Offers Contactless Surgery for Uterine Fibroids 3Health News:Singapore Premier Women's Hospital Offers Contactless Surgery for Uterine Fibroids 4Health News:Shopping for a Vacuum Cleaner? Know What You're Buying! Internet Site and Rating System Can Help 2Health News:Shopping for a Vacuum Cleaner? Know What You're Buying! Internet Site and Rating System Can Help 3Health News:Frost & Sullivan Lauds Aesku.Diagnostics For Providing an Overall Analysis Platform For a Wide Range of Autoimmune Complications 2Health News:Frost & Sullivan Lauds Aesku.Diagnostics For Providing an Overall Analysis Platform For a Wide Range of Autoimmune Complications 3Health News:Frost & Sullivan Lauds Aesku.Diagnostics For Providing an Overall Analysis Platform For a Wide Range of Autoimmune Complications 4Health News:CMPMedica Signs an Agreement With MAIDIS for e-prescribing Solutions in Abu Dhabi (UAE) 2Health News:CMPMedica Signs an Agreement With MAIDIS for e-prescribing Solutions in Abu Dhabi (UAE) 3Health News:Papua New Guinea declares first national conservation area 2Health News:Papua New Guinea declares first national conservation area 3Health News:Papua New Guinea declares first national conservation area 4
(Date:12/16/2009)... Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: ... 2010 the U.S. Food and Drug Administration,s ... the New Drug Application (NDA) for pixantrone ... lymphoma (NHL). ODAC is an independent panel ... efficacy and safety of marketed and investigational ...
(Date:12/16/2009)... Today, a group of national medical societies ... 3590, the Patient Protection and Affordable Care Act, currently ... way towards a final vote in the coming days. ... to vote against a health care bill that is ... hand that our health care system needs reform - ...
(Date:12/16/2009)... , Dec. 16 MedSolutions ( ... management services, today commended two new studies highlighting ... scans and other diagnostic imaging tests. ,, ... proper diagnosis and treatment," said Gregg Allen, M.D., ... studies offer more compelling evidence that stricter quality ...
Breaking Medicine Technology:Cell Therapeutics Announces FDA's Oncologic Drugs Advisory Committee to Review Pixantrone for the Treatment of Relapsed/Refractory Aggressive Non-Hodgkin's Lymphoma, February 10, 2010 2Cell Therapeutics Announces FDA's Oncologic Drugs Advisory Committee to Review Pixantrone for the Treatment of Relapsed/Refractory Aggressive Non-Hodgkin's Lymphoma, February 10, 2010 3Cell Therapeutics Announces FDA's Oncologic Drugs Advisory Committee to Review Pixantrone for the Treatment of Relapsed/Refractory Aggressive Non-Hodgkin's Lymphoma, February 10, 2010 4Physician Groups Oppose Current Senate Health Care Reform Bill 2MedSolutions Applauds Renewed Focus on the Dangers of Radiation Exposure 2MedSolutions Applauds Renewed Focus on the Dangers of Radiation Exposure 3PARI LC Plus and PRONEB Ultra Used in Two Perforomist Studies on Improving COPD Therapies 4671 1PARI LC Plus and PRONEB Ultra Used in Two Perforomist Studies on Improving COPD Therapies 4671 2Pennsylvania Department of Health Workshops Will Help Businesses Prepare for Flu Pandemic 50436 1Pennsylvania Department of Health Workshops Will Help Businesses Prepare for Flu Pandemic 50436 2Spanish Government Selects Novavaxs VLP Technology for Comprehensive Flu Vaccine Solution in Spain 12852 1Spanish Government Selects Novavaxs VLP Technology for Comprehensive Flu Vaccine Solution in Spain 12852 2Spanish Government Selects Novavaxs VLP Technology for Comprehensive Flu Vaccine Solution in Spain 12852 3Spanish Government Selects Novavaxs VLP Technology for Comprehensive Flu Vaccine Solution in Spain 12852 4Spanish Government Selects Novavaxs VLP Technology for Comprehensive Flu Vaccine Solution in Spain 12852 5
For use with catalog #0454....
Determination of FDP in Plasma by Latex Agglutination, 60 tests.Microlatex particles coated with mouse monoclonal anti-human FDP antibodies....
Lupus Anticoagulant-Sensitive APTT Reagent.Cephalin with particulate activator (silica), freeze-dried....
Detection of Lupus Anticoagulants. Freeze-dried hexagonal phase phos-phatidylethanolamine; normal plasmawith heparin inhibitor; PTT-LS reagent of cephalin and particulate siliceous activator;all free...
Medicine Products: